These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1181022)

  • 21. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
    Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Latent porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1989; (4):64-8. PubMed ID: 2763712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ascorbate status of patients with porphyria cutanea tarda symptomatica and its effect on porphyrin metabolism.
    Percy VA; Naidoo D; Joubert SM; Pegoraro RJ
    S Afr J Med Sci; 1975; 40(4):185-96. PubMed ID: 1209393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical findings in porphyria cutanea tarda].
    Heilmann E; Vakilzadeh F
    Fortschr Med; 1977 Mar; 95(10):659-61. PubMed ID: 844765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron and porphyria cutanea tarda.
    D'Alessandro Gandolfo L; Griso D; Macrì A; Biolcati G; Barlattani A; Topi GC
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):75-9. PubMed ID: 9074791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diet and alcohol effects on the manifestation of hepatic porphyrias.
    Cripps DJ
    Fed Proc; 1987 Apr; 46(5):1894-900. PubMed ID: 3556614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic aspects of porphyria cutanea tarda.
    Lambrecht RW; Thapar M; Bonkovsky HL
    Semin Liver Dis; 2007 Feb; 27(1):99-108. PubMed ID: 17295179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease.
    Baravalle E; Prieto J
    Gastroenterology; 1983 Jun; 84(6):1483-91. PubMed ID: 6840477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cutaneous porphyrias.
    Elder GH
    Semin Dermatol; 1990 Mar; 9(1):63-9. PubMed ID: 2203445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of porphyria cutanea tarda with and without phlebotomy (author's transl)].
    Leonhardi G; Klähn KH; Gürenci J
    MMW Munch Med Wochenschr; 1977 Jan; 119(2):43-6. PubMed ID: 401939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen-induced porphyria cutanea tarda. Report of three cases.
    Roenigk HH; Gottlob ME
    Arch Dermatol; 1970 Sep; 102(3):260-6. PubMed ID: 5456016
    [No Abstract]   [Full Text] [Related]  

  • 33. Porphyria cutanea tarda in association with hemosiderosis of the liver. Iron absorption studies and evaluation of therapy by phlebotomy.
    Strickland GT
    Am J Gastroenterol; 1968 Sep; 50(3):202-7. PubMed ID: 5677557
    [No Abstract]   [Full Text] [Related]  

  • 34. Porphyria cutanea tarda. New facts on aetiology, pathogenesis clinical manifestations and treatment.
    Malina L; Chlumský J; Chlumská A
    Acta Univ Carol Med Monogr; 1974; (59):1-126. PubMed ID: 4616623
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
    Horkay I; Nagy E
    Z Hautkr; 1980 Jun; 55(12):813-6. PubMed ID: 7415362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of high fiber vegetable-fruit diet on the activity of liver damage and serum iron level in porphyria cutanea tarda (PCT).
    Dabrowska E; Jabłońska-Kaszewska I; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():282-6. PubMed ID: 12211737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porphyria cutanea tarda associated with lymphoma.
    Maughan WZ; Muller SA; Perry HO
    Acta Derm Venereol; 1979; 59(1):55-8. PubMed ID: 84468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Does paraneoplastic porphyria cutanea tarda exist?].
    Köstler E
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(1):35-40. PubMed ID: 3371236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
    Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF
    Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of hepatitis C virus in porphyria cutanea tarda hepatopathy].
    Quecedo L; Costa J; Enríquez de Salamanca R
    Med Clin (Barc); 1996 Mar; 106(9):321-4. PubMed ID: 8667696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.